Home › Therapeutic areas › Oncology › Waldenstrom Macroglobulinemia
Waldenstrom Macroglobulinemia (3 companies)
Companies with an active program in Waldenstrom Macroglobulinemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CLRB | Cellectar Biosciences | Oncology | 1 | Phase 2 | $11.8M | 6 |
| IBRX | ImmunityBio | Infectious DiseaseOncology | 1 | Approved | $9.15B | 16 |
| NRIX | Nurix Therapeutics | ImmunologyNeurology+1 | 1 | Phase 3 | $1.67B | 13 |
No companies match.